Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) ...

FDA Drug Recall #D-0990-2019 — Class III — March 1, 2019

Recall Summary

Recall Number D-0990-2019
Classification Class III — Low risk
Date Initiated March 1, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm AVKARE Inc.
Location Pulaski, TN
Product Type Drugs
Quantity a) 2947 and b) 3379

Product Description

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide.

Lot / Code Information

Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020

Other Recalls from AVKARE Inc.

Recall # Classification Product Date
D-1329-2022 Class III Lamotrigine Tablets, USP 100 mg, 1000-count bot... Jul 20, 2022
D-0631-2021 Class III Phytonadione Tablets 5 mg, Rx Only, 30 Tablets ... Jun 9, 2021
D-0168-2021 Class I TraZODONE Hydrochloride Tablets USP 100 mg, Rx ... Dec 7, 2020
D-0167-2021 Class II Sildenafil Tablets USP 100 mg, Rx Only, 100-cou... Dec 7, 2020
D-0070-2021 Class II Mesalamine Delayed-Release Tablets, USP 1.2 gra... Oct 30, 2020

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.